Cue Biopharma announced that Matteo Levisetti, M.D., senior vice president, SVP, of clinical development at Cue Biopharma, has been promoted to Chief Medical Officer, CMO, effective January 17, 2023. Current acting CMO Kenneth Pienta, M.D., has transitioned from his current role and will serve as a clinical advisor to the company effective as of the same date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CUE: